ARTICLE | Clinical News
Axanum aspirin/esomeprazole magnesium regulatory update
June 7, 2010 7:00 AM UTC
FDA issued a complete response letter for an NDA for Axanum aspirin/esomeprazole to reduce the risk of low-dose aspirin-associated gastric and/or duodenal ulcers. AstraZeneca did not disclose details ...